WallStreetZenWallStreetZen

NASDAQ: RXRX
Recursion Pharmaceuticals Inc Stock Ownership - Who owns Recursion Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Recursion Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ben R. TaylorChief Financial Officer2025-12-2921,383$4.18
$89.38kSell
Najat KhanChief RD Commercial Officer2025-12-22124,403$4.41
$548.62kSell
Christopher GibsonChief Executive Officer2025-12-1940,000$4.50
$180.00kSell
Ben R. TaylorChief Financial Officer2025-12-157,057$4.33
$30.56kSell
Christopher GibsonChief Executive Officer2025-12-0440,000$4.63
$185.20kSell
Blake BorgesonDirector2025-12-02220,000$4.37
$961.40kSell
Ben R. TaylorChief Financial Officer2025-11-252,271$4.03
$9.15kSell
Christopher GibsonChief Executive Officer2025-11-1940,000$4.16
$166.40kSell
Najat KhanChief RD Commercial Officer2025-11-1717,584$4.14
$72.80kSell
Ben R. TaylorChief Financial Officer2025-11-1711,908$4.14
$49.30kSell

1 of 5

RXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RXRX insiders and whales buy or sell their stock.

RXRX Shareholders

What type of owners hold Recursion Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc7.64%39,780,153$164.29MInstitution
Ark Investment Management LLC6.44%33,545,499$138.54MInstitution
Blackrock Inc6.10%31,739,765$131.09MInstitution
Lux Ventures IV LP5.82%30,308,614$125.17MInsider
Baillie Gifford Co4.61%23,978,695$99.03MInstitution
State Street Corp3.51%18,268,925$75.45MInstitution
Softbank Group Corp2.82%14,667,491$60.58MInstitution
Kinnevik Ab Publ2.58%13,434,171$55.48MInstitution
Mubadala Investment Co Pjsc2.49%12,985,927$53.63MInstitution
MIC Capital Management Uk LLP1.85%9,644,032$39.83MInstitution

1 of 3

RXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RXRX62.25%13.31%Net SellingNet Selling
GLPG47.65%0.00%
HRMY76.19%23.81%Net SellingNet Selling
AUPH49.82%12.61%Net BuyingNet Selling
RARE85.63%14.37%Net SellingNet Selling
View Top Biotech Stocks

Recursion Pharmaceuticals Stock Ownership FAQ

Who owns Recursion Pharmaceuticals?

Recursion Pharmaceuticals (NASDAQ: RXRX) is owned by 62.25% institutional shareholders, 13.31% Recursion Pharmaceuticals insiders, and 24.44% retail investors. Lux Ventures IV LP is the largest individual Recursion Pharmaceuticals shareholder, owning 30.31M shares representing 5.82% of the company. Lux Ventures IV LP's Recursion Pharmaceuticals shares are currently valued at $124.57M.

If you're new to stock investing, here's how to buy Recursion Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.